CRC Postdoctoral Research Fellow

Posted:
8/12/2024, 7:45:11 AM

Location(s):
Illinois, United States ⋅ Chicago, Illinois, United States

Experience Level(s):
Mid Level ⋅ Senior

Field(s):
Medical, Clinical & Veterinary

Workplace Type:
On-site

Passionate about precision medicine and advancing the healthcare industry?

Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.

We are looking for an exceptional postdoctoral fellow to study and advance precision oncology in colorectal cancer (CRC) using one of the world’s largest clinicogenomic databases. The successful candidate will apply computational methods to real-world patient data, comprising genomic, transcriptomic, histopathological, and/or clinical data, to improve our understanding of CRC and advance the application of precision medicine to improve patient outcomes. The successful candidate will join a dynamic and collaborative computational biology group, and develop independent research projects tackling challenging problems in genomic-guided medicine.

Tempus, in partnership with the Fight Colorectal Cancer (Fight CRC), created the Fight CRC Postdoctoral Fellowship in Colorectal Cancer to encourage and further the careers of postdoctoral fellows who are conducting cutting-edge clinicogenomic cancer research, specifically in colorectal cancer. Embedded within Tempus as on onsite researcher, the postdoctoral fellow will have direct access to over 150k de-identified samples with genomic and clinical data, a large organoid repository with genomic and pharmacological screening data, a huge computational environment, and mentorship and collaboration from clinicians, molecular biologists, and data scientists. 

Duration: 2-3 years

Requirements:

  • PhD in Computational Biology, Bioinformatics or related field OR PhD and/or MD with extensive experience in clinical & translational cancer research
  • Demonstrated record of innovative scientific accomplishments as evidenced by at least one first-author or co-first author key paper in a top journal
  • Demonstrated ability to design and execute studies bridging molecular and clinical cancer data
  • Enjoy working in a collaborative environment across departments
  • Excellent communication and organizational skills
  • Proficient in R, Python or other analytical programming language OR desire to acquire analytical skills and link with clinical/translational domain knowledge 

Tempus is a healthcare technology company at the forefront of the expansion of multi-modal healthcare data and the application of artificial intelligence (AI) to fundamentally change cancer care.  Tempus' proprietary platform connects an entire ecosystem of real-world data to deliver real-time, actionable insights enabling physicians to drive better outcomes through precise, individualized care.  Our data accelerates the pace of innovation, empowering researchers to characterize disease, discover new opportunities, maximize clinical trial success, and ensure new therapies reach the right patients. 

Fight Colorectal Cancer (Fight CRC) is a leading patient-empowerment and advocacy organization in the United States, providing balanced and objective information on colon and rectal cancer research, treatment, and policy. We are relentless champions of hope, focused on funding promising, high-impact research endeavors while equipping advocates to influence legislation and policy for the collective good. 

 

#LI-GL1
#LI-Hybrid

We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Tempus

Website: https://www.tempus.com/

Headquarter Location: Chicago, Illinois, United States

Employee Count: 1001-5000

Year Founded: 2015

IPO Status: Private

Last Funding Type: Debt Financing

Industries: Artificial Intelligence (AI) ⋅ Biotechnology ⋅ Health Care ⋅ Machine Learning ⋅ Medical ⋅ Precision Medicine